{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:12:07Z","timestamp":1698667927450},"reference-count":28,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,6,7]],"date-time":"2005-06-07T00:00:00Z","timestamp":1118102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:<\/jats:bold> Epidemiological studies have demonstrated strong links between <jats:italic>Helicobacter pylori<\/jats:italic> infection and gastric adenocarcinoma. Recent studies suggest that cell\u2010mediated immunity influences the outcome of infection, including the development of gastric adenocarcinoma. The T\u2010cell response can be characterized in terms of the secreted cytokine profile, which in turn influences the B\u2010cell response including the balance of IgG subclass antibody.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Serum anti\u2010<jats:italic>H.\u2003pylori<\/jats:italic> IgG, IgG1 and IgG2 antibodies were studied by ELISA in subjects with benign gastric diseases, gastric dysplasia and gastric adenocarcinoma.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The distribution patterns of IgG subclass anti\u2010<jats:italic>H.\u2003pylori<\/jats:italic> antibody varies significantly between <jats:italic>H.\u2003pylori<\/jats:italic>\u2010linked benign and malignant disease in subjects infected with <jats:italic>H.\u2003pylori<\/jats:italic>. Significantly lower IgG2 levels were found in subjects with gastric adenocarcinoma compared with those with reflux esophagitis, chronic gastritis, gastric ulcer, and peptic ulcer, while IgG1 antibody remained at similar levels in both benign and malignant disease. A limited study of seropositive subjects with premalignant change was consistent with the fall in IgG2 antibody pre\u2010dating malignant change, although pre\u2010eradication results are needed to validate these data.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> These studies indicate that subjects with low levels of IgG2 anti\u2010<jats:italic>H.\u2003pylori<\/jats:italic> antibody are at risk of gastric adenocarcinoma, and that the previously described linkage between gastric adenocarcinoma and low total IgG antibody does not simply reflect reduced gastric colonization. The diagnostic value of this assay for pre\u2010endoscopy screening is attractive.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2005.03859.x","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T13:59:33Z","timestamp":1123682373000},"page":"1338-1343","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Selective reduction of anti\u2010<i>Helicobacter pylori<\/i> IgG subclass antibody in gastric carcinoma"],"prefix":"10.1111","volume":"20","author":[{"given":"ZHIGANG","family":"REN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOM","family":"BORODY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GERALD","family":"PANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIANG\u2010CHEN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARGARET","family":"DUNKLEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROBERT","family":"CLANCY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.35.1.292-294.1997"},{"key":"e_1_2_6_3_2","first-page":"1138","article-title":"Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta\u2010analysis","volume":"91","author":"Loy CT","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/iai.64.9.3491-3496.1996","article-title":"Partial characterization of a cell proliferation\u2010inhibiting protein produced by Helicobacter pylori","volume":"64","author":"Knipp U","year":"1996","journal-title":"Infect. Immun."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90938-D"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110173251603"},{"key":"e_1_2_6_7_2","first-page":"177","article-title":"Schistosomes, liver flukes and Helicobacter pylori","volume":"61","author":"International Agency for Research on Cancer (WHO).","year":"1994","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509096307"},{"key":"e_1_2_6_9_2","first-page":"S71","article-title":"The prevalence of Helicobacter pylori infection in gastric cancer","volume":"9","author":"Forman D","year":"1995","journal-title":"Aliment. Pharmacol. Ther."},{"key":"e_1_2_6_10_2","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process\u2010first American Cancer Society Award Lecture on cancer epidemiology and prevention","volume":"52","author":"Correa P","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655202753416795"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02385.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/334255a0"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/apm.1965.64.1.31"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.3.488"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.07121.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2001.091205.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529209165432"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655201750065898"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.d01-634.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1995.tb03544.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.4049\/jimmunol.159.11.5687","article-title":"Suppression of collagen\u2010induced arthritis by continuous administration of IL\u20104","volume":"159","author":"Horsfall AC","year":"1997","journal-title":"J. Immunol."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690283"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1482::AID-CNCR6>3.0.CO;2-D"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<511::AID-CNCR19>3.0.CO;2-1"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1128\/iai.65.9.3509-3512.1997","article-title":"Low antigenicity of the polysaccharide region of Helicobacter pylori lipopolysaccharides derived from tumours of patients with gastric cancer","volume":"65","author":"Yokota S","year":"1997","journal-title":"Infect. Immun."},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1128\/IAI.66.6.3006-3011.1998","article-title":"Human antibody response to Helicobacter pylori lipopolysaccharide: presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide","volume":"66","author":"Yokota S","year":"1998","journal-title":"Infect. Immun."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92340-3"},{"key":"e_1_2_6_29_2","first-page":"1785","article-title":"Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country","volume":"91","author":"Mitchell HM","year":"1996","journal-title":"Am. J. Gastroenterol."}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2005.03859.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2005.03859.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:39:08Z","timestamp":1697315948000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2005.03859.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,10]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1440-1746.2005.03859.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2005.03859.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,10]]},"assertion":[{"value":"2005-08-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}